新一般用医薬品の製造販売後調査結果と適正使用のための情報提供

DOI 被引用文献1件
  • 和田 義男
    エーザイ株式会社信頼性保証本部安全管理部
  • 森 義高
    エーザイ株式会社信頼性保証本部安全管理部
  • 岩渕 令子
    エーザイ株式会社信頼性保証本部安全管理部
  • 井上 法子
    エーザイ株式会社信頼性保証本部安全管理部
  • 滝田 諭
    エーザイ株式会社信頼性保証本部安全管理部
  • 大村 和也
    エーザイ株式会社信頼性保証本部安全管理部
  • 宇田 恒信
    エーザイ株式会社信頼性保証本部安全管理部

書誌事項

タイトル別名
  • Results of a Post-marketing Surveillance Study on a Switch OTC Product and Information Providing for Appropriate Use

この論文をさがす

抄録

Objective: To investigate frequency of adverse drug reactions (ADR) on HIGURD ®<br>, a switch OTC product of azelastine hydrochloride, in a three-year post-marketing surveillance study.<br>Methods: We conducted two surveys in this study a solicited survey with a questionnaire and a survey of spontaneous ADR reports.<br>Results: A total of 183 cases with 293 ADRs were reported in the solicited survey on 3,453 consumers and a total of 29 cases with 37 ADRs were reported from spontaneous sources.  No serious ADRs were reported.  Most frequently reported ADRs were somnolence, thirst, malaise, and dysgeusia, all of which are common on azelastine hydrochloride.  This study indicated that HIGURD ®<br>is well tolerated.<br>Conclusion: This study suggested that efficacy and safety of HIGURD ®<br>depend on how much consumers understand the contents of “Precautions for Use” section of package insert.  It is considered to be effective for safety assurance in an early post-marketing phase that pharmacists inform consumers about appropriate use of HIGURD ®<br>and ask for the occurrence of ADRs.

収録刊行物

  • 医薬品情報学

    医薬品情報学 12 (4), 168-172, 2011

    一般社団法人　日本医薬品情報学会

被引用文献 (1)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ